TCHP and neoplasm: PNKP has been identified as a potential therapeutic target in different types of cancer, as depletion of PNKP in cancer cells or tumor xenografts has shown a synthetic lethal partnership with the loss of the tumor suppressor protein PTEN (24, 33).